cushing's%20syndrome
CUSHING'S SYNDROME
Cushing’s syndrome is a condition which is due to prolonged exposure of the body tissue to excess cortisol (glucocorticoid hormone).
Laboratory tests and radiological findings confirm diagnosis and determine the actual cause of Cushing's syndrome.
Endogenous adrenocorticotropic hormone (ACTH)-independent Cushing's syndrome has adrenal hypersecretion due to adrenal adenoma, adrenal carcinoma, micronodular hyperplasia, and macronodular hyperplasia.
Exogenous ACTH-independent Cushing's syndrome has adrenal hypersecretion due to iatrogenic causes (eg drug-induced, corticosteroid use).

Surgical Intervention

Transsphenoidal Selective Adenomectomy

  • 1st-line therapy for Cushing’s disease
  • Usually performed after inferior petrosal sinus (IPS)
  • A potential cure which keeps pituitary function intact
  • Effects: Generally 80% cure rate (cortisol normalized or rendered hypoadrenal) after initial surgery
    • If 2nd surgery is necessary, it tends to be less successful
  • Different criteria for cure are used eg serum cortisol averaged from 5 readings taken in 1 day: 150-300 nmol/L
  • Patients will generally need glucocorticoid replacement therapy starting after surgery until the hypothalamic-pituitary-adrenal axis has recovered (4-12 months)
  • Complications: Hypopituitarism, diabetes insipidus

Adrenalectomy

  • Unilateral adrenalectomy
    • Cures adrenal adenoma & improves the prognosis of adrenal carcinoma
    • Possibility of remission for Cushing’s disease if pituitary radiotherapy is administered at the same time
  • Total bilateral adrenalectomy
    • A complete cure for adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome
    • Last-line therapy (for patients not cured by other surgical methods or pituitary radiotherapy)
    • May be needed for bilateral micronodular or macronodular hyperplasia
    • May be performed in malignant metastatic tumor of undiagnosed ectopic source
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
03 Sep 2018
Dietary nicotinamide riboside (NR) supplementation in 2,000-mg doses daily over a 12-week period is safe, a recent study has shown. However, it does not improve insulin sensitivity and whole-body glucose metabolism in obese, insulin-resistant men.
07 Apr 2016
Radha Chitale spoke with Dr. Kim A. Williams, Sr., who served as the 2015-2016 president of the American College of Cardiology, during the organization's annual meeting in Chicago, Illinois, US as he reflected on his term and discussed what's exciting in cardiology. 
Dr. Joseph Delano Fule Robles, 25 Jul 2018

Prior to considering pharmacotherapy or surgery, weight reduction can be achieved through dietary modification and management of meal habits, sleep hours and stress.